Biomedical Informatics

Biomedical Informatics 

Biomedical informatics at the University of Massachusetts Medical School (UMMS) provides support for the conduct, administration, analysis, and dissemination of clinical and translational research from bench to clinic to populations. Informatics systems support investigators across the research spectrum in order to: 

Provide leadership and consulting in biomedical informatics across UMass, 

Integrate existing and evolving data repositories, 

Develop and test innovative, reusable informatics tools, middleware, and user interfaces, and 

Provide education and training.

Massachusetts Integrated Clinical Academic Research Database (MICARD)

MICARD is the UMass implementation of the i2b2 (https://www.i2b2.org) informatics platform for clinical research. MICARD helps researchers overcome one of the greatest problems in population-based research: Rapidly compile large groups of well-characterized patients. Qualified investigators may use the MICARD web-based query tool to determine the aggregate total number of patients at participating UMMHC hospitals who meet a given set of inclusion and exclusion criteria (currently demographics, diagnoses, medications, and laboratory values). Because counts are aggregate, patient privacy is protected.  

Conquering Diseases Biorepository 

The aim of the Conquering Diseases Biorepository of the University of Massachusetts Medical School is to obtain patient consented high-quality biospecimens that are linked to de-identified medical information.

REDCap

UMMS is a member of the REDCap Consortium. REDCap (Research Electronic Data Capture) is a secure web application for building and managing online surveys and databases available to UMass investigators.

Biomedical Research Informatics Consulting and Knowledge Service (BRICKS) 

In coordination with the Medical School's Academic and Research Computing Services (ARCS), BRICKS provides expertise and computational resources to the University. BRICKS consults with investigators to support data access, integration, research planning, and provides knowledge to institutional leaders. For more information please contact Ariana Kamberi, Research Coordinator, at Ariana.Kamberi@umassmed.edu or (508)856-8945.

Biomedical Research Development Group (BRIDG)

The BRIDG Core supports human capital-programmers and data managers with unique expertise in informatics standards, data mining, machine learning, and interface-centric middleware programming. BRIDG is in response to unmet translational research needs- to effectively extract data from both coded and free text systems deployed by UMMHC clinical information systems, to assure standards and develop middleware for legacy databases, and to create plug-ins to the UMMHC Information Systems to allow further data acquisition and data representation. For more information please contact Ariana Kamberi, Research Coordinator, at Ariana.Kamberi@umassmed.edu or (508)856-8945.

Department of Quantitative Health Sciences

The vision of the Department of Quantitative Health Sciences (QHS) is to improve population and individudal health by transforming health care delivery through methodological innovation and to become a nationally and internationally recognized resource for translational research.

Program in Bioinformatics and Integrative Biology

The Program in Bioinformatics and Integrative Biology (BIB) was established in 2008 at the University of Massachusetts Medical School to address one of the most dynamic and central areas in biomedical research-the ever-increasing quantity of molecular information available to scientists.

UMMS Quality Assurance Review Center (QARC) Database

The National Cancer Institute (NCI) has independently funded the UMMS Quality Assurance Review Center (QARC) Database for 28 years as a diagnostic imaging and radiation therapy quality assurance vehicle for NCI's Clinical Cooperative Group Clinical Trials Program. QARC has been administratively housed at the UMMS since 1995. Dr. Thomas FitzGerald is the chair of the Department of Radiation Oncology at UMMHC and is the principal investigator of QARC.